Results

Total Results: 275 records

Showing results for "end stage renal".

201. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - organic anion transporter involved in controlling the reabsorption of uric acid from the proximal renal … , diarrhea, and nausea.27 Some preliminary evidence suggests lesinurad could increase the risk of renal … However, better gout management could reduce hospitalizations and renal or cardiovascular complications … provide cost offsets from treatment with lesinurad.38,40 Two research experts noted concerns over renal … have not yet received comments), our overall assessment is that this intervention is in the higher end

202. Chapter 9: Options for Summarizing Medical Test Performance in the Absence of a “Gold Standard” | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-performance/methods
     December 01, 2019 - To this end, the following considerations should be taken into account in the planning stages of the … Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage … renal disease patients: implication for treatment decisions.

203. Interventional Treatments for Acute and Chronic Pain: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/interventional-treatments-pain/protocol
     February 01, 2021 - who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life … Medicare, defined as persons enrolled in Medicare, age >55 years, or persons with disability (including end-stage … renal disease [ESRD]), if available  Population subgroups of interest include those based on demographics … , prior substance use disorder, and psychological co-morbidities)   Patients undergoing end-of-life

204. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
     January 24, 2022 - Every 15 days until end of study period Asymptomatic Total: 18* (8.9)* HIV-: 12 (6.5) HIV+: 6 (33.3) … Hypertension: 14* (26.4) Diabetes:6* (9.4) Liver disease: 0 (0) CVD: 4* (7.5) Asthma:4* (5.7) CKD stage … Nonseroconverter: 22 (66.7) Seroconverter: 59 (59.6) Diabetes: 29 (22) Respiratory disease: 18 (13.6) Renal … the week where they reported having received their first dose of any SARS-CoV-2 vaccine or up to the end … after baseline (for unvaccinated individuals and individuals with one-dose hybrid immunity), death, or end

205. Breast-Cancer-Imaging Technical-Brief (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
     October 01, 2014 - the study questions, the EPC consulted a panel of Key Informants who represent subject experts and end-users … Therefore, in the end, study questions, design, methodological approaches and/or conclusions do not … Because of their role as end-users, individuals with potential conflicts may be retained. … Axillary lymph node dissection in early- stage invasive breast cancer: is it still standard today? … magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal

206. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
     February 01, 2008 - There is usually a postictal phase with confusion that accompanies the end of convulsions. … Partial Neurological: sedation, dizziness, confusion, headache, psychosis Non-Neurological: Anorexia, renal … , generalized, specific epilepsy syndrome), seizure type (new onset, chronic disease), severity or stage … of illness Severity or stage of illness (referral or primary care population) Population Events … $ at the end of a term indicates that this term has been truncated. ?

207. Disposition of Comments for Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
     November 24, 2014 - More information regarding patients’ baseline characteristics, particularly renal clearance, APACHE … results section, we have added more details when available on baseline characteristics, particularly renal … realize that there was an opportunity for public comments on the study design, and that this was the stage … In the Results section we added data on baseline characteristics, particularly renal clearance, APACHE … , or antibiotic-related adverse events differ for subgroups defined by age, sex, race, ethnicity, renal

208. Systematic Review Search Strategy Development Tools: A Practical Guide for Expert Searchers (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/search-strategy-white-paper.pdf
     February 01, 2025 - Individual reviewed tools can be used at more than one stage. … have attempted to provide sufficient information for a user to decide which tools to use in which stage … End Stage Renal Disease and Depression: A Systematic Review. … Javascript converts from one syntax to another and inserts Boolean connectors in at the end of analysis

209. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis—An Update of the 2006 Report. (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
     October 01, 2011 - Revised to clarify that “end of followup” results were through 12 months (page 17, line 15). … observational studies found acetaminophen associated with modest increases in blood pressure or higher risk of renal … Hypertension is the second leading cause of kidney failure or End Stage Renal Disease in the United … Effects of NSAIDs on HTN and renal function are reviewed starting on page 66, line 7. Rosa L. … At the end of the treatment period, absolute differences were statistically significant as compared

210. Comparative Effectiveness of Screening for Methicillin-Resistant Staphylococcus aureus (MRSA) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/mrsa-screening-2010/research-protocol
     December 01, 2019 - Anticipated subgroups include patients at high-risk for MRSA, including those with end-stage renal disease … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

211. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. … risk solid tumors Safety/Efficacy Study 12 4/1999- 9/2012 United States FU: Annually until end … Phase II treatment study 60 (ages 6 to 59 years) 9/1994 - End date not provided United States … weight) Systemic Lupus Erythematosus Disease Activity Index Lupus serology (ANA, dsDNA, C3, C4) Renal … Supportive care intervention 150 (75 per arm) 1/2004 – End date not reported United States

212. Translation of a C. difficile Treatment Clinical Pathway Into Machine-Readable Clinical Decision Support Artifacts Prototyped for Electronic Health Record Implementation (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
     November 01, 2019 - Matter Experts and Clinical Informaticists Improved Clinical Accuracy and Usability of the Final CDS End … To that end, this AHRQ EPC methods project had two primary aims: 1. … Development of Tools and an Environment for Conducting End User L3 and L4 Artifact Testing To Assess … In the software development lifecycle, this stage of testing is often referred to as “black box” testing … implementing a computerized clinical decision support system for medication dosing for patients with renal

213. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
     March 01, 2012 - Based on this input, our overall assessment is that this intervention is in the lower end of the … glucose levels in urine were reported in some trials. 76 Additionally, long-term safety data on renal … Experts believe that the proposed mechanism of action of reducing blood glucose levels by preventing renal … Lilly and Amylin mutually agree to end diabetes alliance and transition exenatide responsibility to … Selected pharmaceuticals in late stage U.S. and E.U. development or registration.

214. Mrsa-Screening-2010 Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mrsa-screening-2010_research-protocol.pdf
     January 01, 2010 - Anticipated subgroups include patients at high-risk for MRSA, including those with end-stage renal … Key Informants Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

215. Disposition of Comments for Technical Brief 27 Patient Safety (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
     October 19, 2016 - Thus my 1st several readings left me w/ a feeling that it seems to almost "end before it begins." … sentences, legible orders, medication list maintenance, some decision- support successes (allergies, renal … No response needed Peer Reviewer #5 Background I thought this set the stage nicely. … I assume that keeping them anonymous at this stage is standard practice, but it would help to have a … It is AHRQ practice to keep them anonymous at the draft stage.

216. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - disease, thyroid disorders 5.4 Others: tumoral obstruction, fibrosing mediastinitis, chronic renal … Limited data suggest that epoprostenol and bosentan may provide a survival benefit; however, this end … At the full- text screening stage, two independent reviewers read each article to determine if it met … Of these, 1,127 were excluded at the full-text screening stage, leaving 197 articles (representing … – Consider studies of additional promising measures such as end diastolic pulmonary regurgitation

217. Meditation Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
     January 01, 2014 - • Was attrition <20% at the end of treatment? … One trial specified that the researchers looked for toxicities of meditation to hematologic, renal, … Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage … Change in women’s diet and body mass following intensive intervention for early-stage breast cancer … effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage

218. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - also increases the risk of several types of cancer including colorectal, endometrial, esophageal, renal … The phentermine plus topiramate combination is administered daily as an oral medication. 3 In late-stage … Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential-impact … Based on this input, our overall assessment is that this intervention is in the lower end of the high

219. Noninvasive Testing for Coronary Artery Disease | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/coronary-artery-disease-testing/research-protocol
     December 01, 2019 - Harms, risks and consequences of testing Procedural harms, adverse events of testing (e.g., renal … , risks and consequences of testing (both initial and subsequent testing): Harms of testing (renal … Thus, to set the stage for the review’s Key Questions, which are focused on clinical decisionmaking and … Key Informants Key informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as key informants and those who

220. Safety of Vaccines Used for Routine Immunization in the United States | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/safety-vaccines/protocol
     January 01, 2021 - transplantation: official publication of the European Dialysis and Transplant Association - European Renal … Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage … renal disease population unresponsive to primary vaccination series. … Renal failure. 2015;37(7):1080-8. Zafack JG, De Serres G, Kiely M, et al. … Nervous system disorders Pregnancy, puerperium and perinatal conditions Psychiatric disorders Renal